Literature DB >> 16026863

Assessment of IgM enzyme immunoassay and IgG avidity assay for distinguishing between primary and secondary immune response to rubella vaccine.

Rasool Hamkar1, Somayeh Jalilvand, Talat Mokhtari-Azad, Keramat Nouri Jelyani, Hosein Dahi-Far, Hoorieh Soleimanjahi, Rakhshandeh Nategh.   

Abstract

The primary test for the laboratory confirmation of rubella is IgM serology. It is important to distinguish IgM reactivity caused by primary infection from that caused by reinfection or persistence, especially in pregnant women; as termination of pregnancy is considered when primary rubella is diagnosed during the first trimester. In this study, the performance of rubella IgM enzyme immunoassay (IgM-EIA) and rubella IgG avidity assay were compared using well-defined panels of sera from persons vaccinated against rubella and commercial rubella IgM and IgG enzyme immunoassay kits (Dade Behring, Marburg, Germany). The sensitivity and specificity of rubella IgM-EIA were found to be 77.4 and 97.9%, respectively, while the results for rubella IgG avidity assay were 100 and 100%. IgG avidity assay showed higher positive and negative predictive values than the IgM-EIA (100 and 100% compare to 96.9 and 82.9%). In conclusion, the rubella IgG avidity assay is more sensitive and specific than IgM-EIA for differential detection of primary rubella infection from rubella reinfection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16026863     DOI: 10.1016/j.jviromet.2005.06.003

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  9 in total

1.  Evaluation of commercial rubella immunoglobulin G avidity assays.

Authors:  Samira Mubareka; Hannah Richards; Michael Gray; Graham A Tipples
Journal:  J Clin Microbiol       Date:  2006-11-08       Impact factor: 5.948

2.  Performance characteristics of current-generation Immulite 2000 TORCH Assays.

Authors:  A R Centonze; E Tonolli; R Fontana
Journal:  Clin Vaccine Immunol       Date:  2012-11-21

3.  Acute Rubella Virus Infection among Women with Spontaneous Abortion in Mwanza City, Tanzania.

Authors:  Lukombodzo Lulandala; Mariam M Mirambo; Dismas Matovelo; Balthazar Gumodoka; Stephen E Mshana
Journal:  J Clin Diagn Res       Date:  2017-03-01

4.  Incorporation of antigens into viral capsids augments immunogenicity of adeno-associated virus vector-based vaccines.

Authors:  Jan Rybniker; Angela Nowag; Hanna Janicki; Kai Demant; Pia Hartmann; Hildegard Büning
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

5.  Unusual patterns of IgG avidity in some young children following two doses of the adjuvanted pandemic H1N1 (2009) influenza virus vaccine.

Authors:  Karen K Yam; Jyotsana Gupta; Angela Brewer; David W Scheifele; Scott Halperin; Brian J Ward
Journal:  Clin Vaccine Immunol       Date:  2013-01-23

Review 6.  Advances in pemphigus and its endemic pemphigus foliaceus (Fogo Selvagem) phenotype: a paradigm of human autoimmunity.

Authors:  Donna A Culton; Ye Qian; Ning Li; David Rubenstein; Valeria Aoki; Gunter Hans Filhio; Evandro A Rivitti; Luis A Diaz
Journal:  J Autoimmun       Date:  2008-10-05       Impact factor: 7.094

7.  Reduction in Rubella Virus Active Cases among Children and Adolescents after Rubella Vaccine Implementation in Tanzania: A Call for Sustained High Vaccination Coverage.

Authors:  Fausta Michael; Mariam M Mirambo; Dafrossa Lyimo; Furaha Kyesi; Delfina R Msanga; Georgina Joachim; Honest Nyaki; Richard Magodi; Delphius Mujuni; Florian Tinuga; Ngwegwe Bulula; Bonaventura Nestory; Dhamira Mongi; Ahmed Makuwani; Betina Katembo; William Mwengee; Alex Mphuru; Nassor Mohamed; David Kayabu; Helmut Nyawale; Eveline T Konje; Stephen E Mshana
Journal:  Vaccines (Basel)       Date:  2022-07-27

Review 8.  Serological makers of rubella infection in Africa in the pre vaccination era: a systematic review.

Authors:  Mariam M Mirambo; Mtebe Majigo; Said Aboud; Uwe Groß; Stephen E Mshana
Journal:  BMC Res Notes       Date:  2015-11-25

9.  Serological evidence of acute rubella infection among under-fives in Mwanza: a threat to increasing rates of congenital rubella syndrome in Tanzania.

Authors:  Mariam M Mirambo; Said Aboud; Martha F Mushi; Mwanaisha Seugendo; Mtebe Majigo; Uwe Groß; Stephen E Mshana
Journal:  Ital J Pediatr       Date:  2016-05-25       Impact factor: 2.638

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.